NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
29.64
-0.91 (-2.98%)
At close: Jul 24, 2026, 4:00 PM EDT
30.09
+0.45 (1.52%)
After-hours: Jul 24, 2026, 7:58 PM EDT
NewAmsterdam Pharma Company Employees
NewAmsterdam Pharma Company had 100 employees as of December 31, 2025. The number of employees increased by 32 or 47.06% compared to the previous year.
Employees
100
Change
32
Growth
47.06%
Revenue / Employee
$225,650
Profits / Employee
-$2,127,330
Market Cap
3.47B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 100 | 32 | 47.06% |
| Mar 31, 2025 | 77 | 37 | 92.50% |
| Dec 31, 2024 | 68 | 39 | 134.48% |
| Sep 30, 2024 | 62 | 40 | 181.82% |
| Jun 30, 2024 | 57 | 35 | 159.09% |
| Mar 31, 2024 | 40 | 23 | 135.29% |
| Dec 31, 2023 | 29 | 12 | 70.59% |
| Jun 30, 2023 | 22 | - | - |
| Dec 31, 2022 | 17 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| Arcus Biosciences | 601 |
| Denali Therapeutics | 507 |
| Arcutis Biotherapeutics | 354 |
| Dyne Therapeutics | 263 |
| Structure Therapeutics | 233 |
| Alumis | 227 |
| IDEAYA Biosciences | 145 |
NAMS News
- 13 hours ago - NewAmsterdam announces positive CHMP opinion for Ubeslo and Evlarco - TheFly
- 16 hours ago - NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination) - GlobeNewsWire
- 4 days ago - NewAmsterdam Pharma initiated with an Outperform at BMO Capital - TheFly
- 22 days ago - NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 23 days ago - NewAmsterdam Pharma Announces Upcoming Presentations at the Alzheimer's Association International Conference (AAIC) 2026 - GlobeNewsWire
- 24 days ago - NewAmsterdam Pharma price target raised to $51 from $47 at RBC Capital - TheFly
- 6 weeks ago - NewAmsterdam Pharma Company Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - NewAmsterdam Pharma Company Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts